Abstract: Objective Curcumin is extracted from the turmeric plant (Curcuma longa Linn.) and is widely used as a food additive and traditional medicine. The present study investigated the activity of curcumin against staurosporine (STS) toxicity in cell culture. Methods Rat hippocampal neurons in primary culture were exposed to STS (20 µmol/L) and treated with curcumin (20 µmol/L). Cell viability was tested by MTT assay and reactive oxygen species (ROS) were measured using the MitoSOX™ red mitochondrial superoxide indicator. Western blot was used to assess changes in the levels of caspase-3 (Csp3), heat shock protein 70 (Hsp70) and Akt. Results The results showed that curcumin protects against STS-induced cytotoxicity in rat hippocampal neurons. Csp3, Hsp70, Akt and ROS activation may be involved in this protection. Conclusion Curcumin could be a potential drug for combination with STS in cancer treatment to reduce the unwanted cytotoxicity of STS.
Introduction
Staurosporine (STS) is a cell-permeable, prototypical alkaloid of the indolocarbazole family and was first discovered in 1977 in a screen for microbial alkaloids [1] .
It was isolated from the bacterium Streptomyces stauroporeus, and then from other actinomycetes [2] . It is stable in serum [1] and its antifungal and hypotensive activities were described first. Later, it was reported that STS is a potent inhibitor of protein kinase C and therefore toxic to various cells, including cancer cells [3] . Since then, several STS analogs have been discovered in marine invertebrates, such as sponges, tunicates, bryozoans and mollusks [4] , and have been synthesized [4] . Clinical trials have been carried out for analogs aiming at targeted cytotoxicity to cancer cells and relatively low toxicity to other cells [4] .
Curcumin is extracted from Curcuma longa Linn.
(turmeric), a member of the ginger family with a long history as a spice, medicine, food additive and dye in south and southeast Asia, especially India [5] . Its chemical structure was reported in 1815 [5] . Curcumin is suggested to be a more potent anti-oxidant than vitamin E α-tocopherol [6] .
It has also been reported to have anti-inflammatory effects through inhibiting transcription related to cytokine regulation [7] and suppressing inducible nitric oxide synthase in Xiao-Yan Qin, et al. Curcumin protects against STS toxicity 607 activated macrophages [8] . In addition, curcumin prevents the formation of amyloid β (Aβ) aggregates in the submicromolar range [9] and protects against Aβ toxicity in primary cultures of rat neurons [10] . Because of its protective property, we hypothesized that curcumin may protect against STS cytotoxicity in neurons and therefore may be a potential drug to combine with STS in cancer treatment to reduce the unwanted cytotoxicity.
Therefore, we set out to determine whether curcumin is protective against STS toxicity and, if so, the likely mechanism of action.
Materials and methods

Primary cell culture and treatments Newborn
Sprague-Dawley rat pups were provided by the Experi- were added to the culture medium during treatment. Immunoblots were developed with enhanced chemiluminescence reagents, and the images detected in ChemiDox (Bio-Rad). The relative density was calculated by the total absolute density of (active Csp3/GAPDH)*100, (Akt/ GAPDH)*100 or (Hsp70/GAPDH)*100.
Cell viability and death assays
Statistical evaluation
All data are presented as mean ± SEM. The statistical significance of differences (*P <0.05 or **P <0.01) among groups was determined by two-way 
Results
Curcumin protects against STS-induced cytotoxicity
MTT assays demonstrated that STS (20 µmol/L) induced cytotoxicity in primary cultures of rat hippocampal neurons after 24-h exposure (Fig. 1A) and curcumin (20 µmol/L) effectively protected against STS toxicity by increasing the viability by ~20% compared with STS alone (Fig. 1A) . by STS (Fig. 2A) . Hsp70 is reported to protect against various insults [11] [12] [13] [14] , so we measured its levels. Curcumin significantly increased the Hsp70 level when applied with STS, suggesting that Hsp70 activation may be involved in the protection (Fig. 2B ). Since the Akt pathway is also implicated in cancer therapy [15] , its relative levels were determined, and the data showed that STS increased the Akt level and curcumin effectively blocked this (Fig. 1C) . 
Discussion
The results of the present study showed that curcumin can protect against STS-induced cytotoxicity in primary cultures of rat hippocampal neurons. Recently, it was reported that curcumin protects against STS-induced cell death in retinal ganglion cells, possibly by regulating NFκB [16] . Here, we showed that ROS, Csp3, Hsp70
and Akt activation may be involved in the protection by curcumin. Curcumin is relatively insoluble in water, but readily dissolves in organic solvents [17] . It is cell-membrane permeable [17] and is relatively stable at physiological pH in the presence of fetal bovine serum or human blood [17] .
Its ability to penetrate the blood-brain barrier is poor and up to 0.5% of intravenous curcumin, which is equivalent to 25 µg/kg, is found in the brain [18] . The beneficial effects of curcumin are consistent with other reports that it is protective in an animal model in which human Aβ is infused with a lipoprotein chaperone into the cerebral ventricles [19] .
Curcumin treatment reverses the change of synaptophysin and post-synaptic density 95 as well as the distance and latency in finding the hidden platform in the water maze test [5] . Synaptic loss and degeneration cause neuronal dysfunction and cell death. Neuronal loss in the cerebral cortex and the hippocampus is a hallmark of neurodegenerative diseases like Alzheimer's disease [20, 21] . A phase II, double-blind, placebo-controlled study of curcumin safety and tolerability in Alzheimers patients is ongoing [5] . These data suggest that curcumin crosses the blood-brain barrier and plays beneficial roles, which makes it a potential candidate for neuroprotection. Our data showed that at high concentrations, curcumin was not protective against STSinduced toxicity. We think this may be explained by the possibility that at high concentrations, it may be cytotoxic.
Although the mechanisms of curcumin protection are not fully understood, in the present study, it increased Hsp70 and decreased activated Csp3, Akt and ROS, suggesting that these factors may be involved in STS toxicity and the protection by curcumin.
Derivatives of STS, such as CGP41251, PKC412, Ro31-8220, CEP-701, CP-751, edotecarin and becatecarin are being investigated as potential anti-cancer drugs in phase II or III studies [4] . Protein kinase inhibition by STS is broadly potent across the kinome, so STS itself is cytotoxic when used alone as an anti-cancer drug [4] . One possible way to solve this problem is to look for or generate STS cognates with a more selective kinase inhibition profile [4] .
On the other hand, application of combinations of STS with other protective agents, such as curcumin, may help to reduce the cytotoxicity. Further studies need to be done to test this hypothesis.
In conclusion, curcumin can prevent cytotoxicity induced by STS in rat hippocampal neurons in culture, probably through the regulation of ROS, csp3, Hsp70 and Akt levels. Our data indicate that curcumin may counteract STS toxicity and can be combined with it during cancer treatment.
